Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jan;108(1):155–161. doi: 10.1111/j.1476-5381.1993.tb13456.x

Influences of the endothelium and hypoxia on alpha 1- and alpha 2-adrenoceptor-mediated responses in the rabbit isolated pulmonary artery.

M R MacLean 1, K M McCulloch 1, J C McGrath 1
PMCID: PMC1907688  PMID: 8094023

Abstract

1. The effects of the inhibitor of nitric oxide synthase, N omega-nitro-L-arginine methylester (L-NAME, 10(-4) M), mechanical disruption of the endothelium and hypoxia on contraction to noradrenaline (alpha 1- and alpha 2-adrenoceptor agonist), phenylephrine (alpha 1-adrenoceptor agonist) and UK 14304 (alpha 2-adrenoceptor agonist) were compared in the rabbit isolated pulmonary artery. The effects of the selective antagonists rauwolscine (10(-6) M, alpha 2-adrenoceptors) and prazosin (10(-7) M, alpha 1-adrenoceptors) on the contractions to noradrenaline before and after exposure to L-NAME were also assessed. 2. Noradrenaline, phenylephrine and UK 14304 all produced concentration-dependent increases in vascular tone. The responses to noradrenaline were sensitive to both rauwolscine and prazosin (effect of prazosin >> rauwolscine). L-NAME increased the potency of both noradrenaline and UK 14304, and also the maximum tension achieved. It had no effect on the responses to phenylephrine. After L-NAME, contractions to noradrenaline, although still sensitive to both rauwolscine and prazosin, were now more sensitive to inhibition by rauwolscine. 3. Endothelium removal augmented the potency and maximum contractions to noradrenaline, phenylephrine and UK 14304. 4. Hypoxia decreased both the potency of phenylephrine and its maximum contractile response, but increased the maximum response to noradrenaline without effecting responses to UK 14304. 5. In conclusion, in the rabbit pulmonary artery, augmentation of contractile responses to noradrenaline by L-NAME involves a potentiation of alpha 2-adrenoceptor-mediated contraction probably through an effect on the synthesis of endothelium-derived nitric oxide.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cocks T. M., Angus J. A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983 Oct 13;305(5935):627–630. doi: 10.1038/305627a0. [DOI] [PubMed] [Google Scholar]
  2. Daly C. J., Gordon J. F., McGrath J. C. The use of fluorescent nuclear dyes for the study of blood vessel structure and function: novel applications of existing techniques. J Vasc Res. 1992 Jan-Feb;29(1):41–48. doi: 10.1159/000158930. [DOI] [PubMed] [Google Scholar]
  3. Dawson C. A. Role of pulmonary vasomotion in physiology of the lung. Physiol Rev. 1984 Apr;64(2):544–616. doi: 10.1152/physrev.1984.64.2.544. [DOI] [PubMed] [Google Scholar]
  4. Dunn W. R., Daly C. J., McGrath J. C., Wilson V. G. A comparison of the effects of angiotensin II and Bay K 8644 on responses to noradrenaline mediated via postjunctional alpha 1-and alpha 2-adrenoceptors in rabbit isolated blood vessels. Br J Pharmacol. 1991 Jun;103(2):1475–1483. doi: 10.1111/j.1476-5381.1991.tb09814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dunn W. R., McGrath J. C., Wilson V. G. Postjunctional alpha-adrenoceptors in the rabbit isolated distal saphenous artery: indirect sensitivity to prazosin of responses to noradrenaline mediated via postjunctional alpha 2-adrenoceptors. Br J Pharmacol. 1991 Jun;103(2):1484–1492. doi: 10.1111/j.1476-5381.1991.tb09815.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Eglème C., Godfraind T., Miller R. C. Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol. 1984 Jan;81(1):16–18. doi: 10.1111/j.1476-5381.1984.tb10736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Holden W. E., McCall E. Hypoxia-induced contractions of porcine pulmonary artery strips depend on intact endothelium. Exp Lung Res. 1984;7(2):101–112. doi: 10.3109/01902148409069671. [DOI] [PubMed] [Google Scholar]
  8. Ignarro L. J., Byrns R. E., Buga G. M., Wood K. S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 1987 Dec;61(6):866–879. doi: 10.1161/01.res.61.6.866. [DOI] [PubMed] [Google Scholar]
  9. Johns R. A., Linden J. M., Peach M. J. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res. 1989 Dec;65(6):1508–1515. doi: 10.1161/01.res.65.6.1508. [DOI] [PubMed] [Google Scholar]
  10. Liu S. F., Crawley D. E., Evans T. W., Barnes P. J. Endogenous nitric oxide modulates adrenergic neural vasoconstriction in guinea-pig pulmonary artery. Br J Pharmacol. 1991 Oct;104(2):565–569. doi: 10.1111/j.1476-5381.1991.tb12469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lues I., Schümann H. J. Effect of removing the endothelial cells on the reactivity of rat aortic segments to different alpha-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol. 1984 Dec;328(2):160–163. doi: 10.1007/BF00512066. [DOI] [PubMed] [Google Scholar]
  12. MacLean M. R., McCulloch K. M., MacMillan J. B., McGrath J. C. Influences of the endothelium and hypoxia on neurogenic transmission in the isolated pulmonary artery of the rabbit. Br J Pharmacol. 1993 Jan;108(1):150–154. doi: 10.1111/j.1476-5381.1993.tb13455.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MacLean M. R., McGrath J. C. Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1990 Sep;101(1):205–211. doi: 10.1111/j.1476-5381.1990.tb12114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marriott J. F., Marshall J. M. Effects of hypoxia upon contractions evoked in isolated rabbit pulmonary artery by potassium and noradrenaline. J Physiol. 1990 Mar;422:15–28. doi: 10.1113/jphysiol.1990.sp017969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miller D. J. May the force be with you. Trends Pharmacol Sci. 1988 Apr;9(4):124–125. doi: 10.1016/0165-6147(88)90191-5. [DOI] [PubMed] [Google Scholar]
  16. Moncada S., Palmer R. M., Higgs E. A. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol. 1989 Jun 1;38(11):1709–1715. doi: 10.1016/0006-2952(89)90403-6. [DOI] [PubMed] [Google Scholar]
  17. Moncada S., Palmer R. M., Higgs E. A. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension. 1988 Oct;12(4):365–372. doi: 10.1161/01.hyp.12.4.365. [DOI] [PubMed] [Google Scholar]
  18. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  19. Papanicolaou M., Medgett I. C. Effects of blockade of alpha 1- and alpha 2-adrenoceptors on vasoconstrictor responses to single and twin pulse stimulation in rat tail artery. Eur J Pharmacol. 1986 Nov 19;131(2-3):211–218. doi: 10.1016/0014-2999(86)90574-1. [DOI] [PubMed] [Google Scholar]
  20. Rabinovitch M., Bothwell T., Hayakawa B. N., Williams W. G., Trusler G. A., Rowe R. D., Olley P. M., Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab Invest. 1986 Dec;55(6):632–653. [PubMed] [Google Scholar]
  21. Rengasamy A., Johns R. A. Characterization of endothelium-derived relaxing factor/nitric oxide synthase from bovine cerebellum and mechanism of modulation by high and low oxygen tensions. J Pharmacol Exp Ther. 1991 Oct;259(1):310–316. [PubMed] [Google Scholar]
  22. Rosenberg H. C., Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988 Dec;255(6 Pt 2):H1484–H1491. doi: 10.1152/ajpheart.1988.255.6.H1484. [DOI] [PubMed] [Google Scholar]
  23. Staub N. C. Site of hypoxic pulmonary vasoconstriction. Chest. 1985 Oct;88(4 Suppl):240S–245S. doi: 10.1378/chest.88.4_supplement.240s. [DOI] [PubMed] [Google Scholar]
  24. Templeton A. G., Macmillan J., McGrath J. C., Storey N. D., Wilson V. G. Evidence for prazosin-resistant, rauwolscine-sensitive alpha-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br J Pharmacol. 1989 Jun;97(2):563–571. doi: 10.1111/j.1476-5381.1989.tb11986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Warren J. B., Maltby N. H., MacCormack D., Barnes P. J. Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. Clin Sci (Lond) 1989 Dec;77(6):671–676. doi: 10.1042/cs0770671. [DOI] [PubMed] [Google Scholar]
  26. Xiao X. H., Rand M. J. Alpha 2-adrenoceptor agonists enhance responses to certain other vasoconstrictor agonists in the rat tail artery. Br J Pharmacol. 1989 Mar;96(3):539–546. doi: 10.1111/j.1476-5381.1989.tb11851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES